| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.539 | 67 | 8.379 | - | - | - | - | - | - | - |
| Total Income - EUR | 3.656 | 68 | 8.379 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 17.209 | 8.106 | 9.039 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -13.553 | -8.037 | -661 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -13.553 | -8.037 | -661 | - | - | - | - | - | - | - |
| Employees | 0 | 0 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Pharmachem Continental S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 149 | 0 | 0 | - | - | - | - | - | - | - |
| Current Assets | 249.367 | 238.219 | 233.341 | - | - | - | - | - | - | - |
| Inventories | 9.765 | 9.634 | 9.471 | - | - | - | - | - | - | - |
| Receivables | 228.085 | 221.023 | 211.611 | - | - | - | - | - | - | - |
| Cash | 11.517 | 7.562 | 12.260 | - | - | - | - | - | - | - |
| Shareholders Funds | 240.036 | 229.551 | 225.005 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Debts | 9.480 | 8.667 | 8.336 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharmachem Continental S.r.l.